Skip to main content
. 2018 Jan 19;9:1–7. doi: 10.2147/JBM.S147743

Figure 3.

Figure 3

Changes in the plasma levels of sVCAM-1, PAI-1, and sEPCR before and after treatments.

Notes: Data are shown as mean ± SD. p-value, patients versus controls.

Abbreviations: Mel-P, melphalan and prednisone; Bor, bortezomib; Len, lenalidomide; sVCAM-1, soluble vascular cell adhesion molecule-1; PAI-1, plasminogen activator inhibitor-1; sEPCR, soluble endothelial protein C receptor; NS, not significant.